Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes.
Mol Metab
; 4(7): 519-27, 2015 Jul.
Article
em En
| MEDLINE
| ID: mdl-26137439
AMPK, AMP-activated protein kinase; Adipokine; Adiponectin; BMI, body mass index; C/EBP-α, CCAAT/enhancer-binding protein-α; CIDEA, cell death-inducing DNA fragmentation factor-like effector a; ERK, extracellular signal-regulated kinase; FGF, fibroblast growth factor; FGF21; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; Hepatokine; IL-6, interleukin-6; MHO, metabolically healthy obesity; MUHO, metabolically unhealthy obesity; PGC-1α, PPAR-γ coactivator-1α; PPAR-γ, peroxisome proliferator-activated receptor-γ; Secretome; Type-2 diabetes; UCP-1, uncoupling protein-1; hasc, human abdominal subcutaneous; qPCR, quantitative polymerase chain reaction; rh, recombinant human
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article